Most definately will be-well at least for the top couple of shareholders.Only way to get more funding will be to give big guys chance to get more at bottom of the barrel price.
RGT Is the ASX OK? Argent Biopharma plummets as it leaves the bourse one day after Marley spoon; low liquidity blamed